Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000426240

Medchemexpress LLC Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-lysyl), 2,2,2-trifluoroacetate (1:1) | 500577-51-5 | 99.6% | 717.69 | 25 MG
SDP

Catalog No. 5000426240
Encompass_Preferred

Cyclo(-RGDfK) TFA is a potent and selective inhibitor of the αvβ3 integrin, with an IC50 of 0.94 nM. This compound targets tumor microvasculature and cancer cells through specific binding to the αvβ3 integrin on the cell surface. It can be prepared with high radiochemical purity and specific activity, showing in vitro stability and moderate protein binding.

  • Potent and selective inhibitor of αvβ3 integrin.
  • IC50 of 0.94 nM for αvβ3 integrin.
  • Targets tumor microvasculature and cancer cells.
  • Exhibits high radiochemical purity (>97%).
  • Shows in vitro stability.
  • Suitable for MicroPET imaging to reflect αvβ3-targeted tracer accumulation.

Catalog No. 50-004-26240 Supplier Medchemexpress LLC Supplier No. 25MGHYP0023A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Cyclo(-RGDfK) TFA is a potent and selective inhibitor of the αvβ3 integrin, with an IC50 of 0.94 nM. This compound targets tumor microvasculature and cancer cells through specific binding to the αvβ3 integrin on the cell surface. It can be prepared with high radiochemical purity and specific activity, showing in vitro stability and moderate protein binding.

  • Potent and selective inhibitor of αvβ3 integrin.
  • IC50 of 0.94 nM for αvβ3 integrin.
  • Targets tumor microvasculature and cancer cells.
  • Exhibits high radiochemical purity (>97%).
  • Shows in vitro stability.
  • Suitable for MicroPET imaging to reflect αvβ3-targeted tracer accumulation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.